NCI Anthony G. Letai to be named NCI directorThe Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say September 25, 2025Vol.51 No.35By Claire Marie Porter and Paul Goldberg
NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium September 19, 2025Vol.51 No.34By Paul Goldberg
NCI NCI releases names of members of ad hoc working group—filling the void left by BSA September 19, 2025Vol.51 No.34By Sara Willa Ernst
AACR Cancer Progress Report makes the case for federal investment in cancer research September 19, 2025Vol.51 No.34By Sara Willa Ernst
Letter To The Editor Urgently needed: A funding mechanism to insulate cancer research from political whims September 19, 2025Vol.51 No.34By Paul W. Thurman
Guest Editorial How today’s uncertainty can motivate young investigators to double down on their passionLessons from my Studs Terkel boxed set September 19, 2025Vol.51 No.34By George J. Weiner
PodcastThe Directors The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” September 12, 2025Vol.51 No.33By Claire Marie Porter, Jacquelyn Cobb and Paul Goldberg
Guest Editorial Reflections of a cancer scientistMaintaining the pace of novel technologies will lead to more efficient and less toxic medicines September 12, 2025Vol.51 No.33By Ze’ev Ronai
Sponsored Breaking barriers in lung cancer research September 12, 2025Vol.51 No.33By Loretta Erhunmwunsee
FreeObituary Nobel laureate David Baltimore dies at 87Baltimore discovered that genetic material of tumor viruses could make DNA from their RNA genome September 12, 2025Vol.51 No.33By Lori Dajose
